<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for IPXL</title>
    <link />
    <description>Headlines for Impax Laboratories Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Impax Launches Generic Zomig - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/100084/impax-launches-generic-zomig.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 23 May 2013 23:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Impax Board of Directors Establishes Compliance Committee</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/impax-board-of-directors-establishes-compliance-co/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 16:21:04 GMT</pubDate>
    </item>
    <item>
      <title>Impax Laboratories to Present at the UBS Global Healthcare Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/20/impax-laboratories-to-present-at-the-ubs-global-he/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 20 May 2013 08:59:42 GMT</pubDate>
    </item>
    <item>
      <title>Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegra</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/17/impax-laboratories-launches-authorized-generic-of-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 17 May 2013 08:47:14 GMT</pubDate>
    </item>
    <item>
      <title>Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/10/impax-laboratories-to-present-at-the-bank-of-ameri/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 10 May 2013 09:35:11 GMT</pubDate>
    </item>
    <item>
      <title>5 Big Bets Revealed By Long/Short Equity Hedge Fund Apex Capital</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1418271-5-big-bets-revealed-by-long-short-equity-hedge-fund-apex-capital.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 08:51:34 GMT</pubDate>
    </item>
    <item>
      <title>Shire Beats Earnings in 1Q - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98608/shire-beats-earnings-in-1q.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 12:54:01 GMT</pubDate>
    </item>
    <item>
      <title>Impax Laboratories Inc. Stock Downgraded (IPXL)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913071/1/impax-laboratories-inc-stock-downgraded-ipxl.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 03 May 2013 05:00:00 GMT</pubDate>
    </item>
    <item>
      <title>IMPAX LABORATORIES 96 HOUR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General a</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/02/impax-laboratories-96-hour-alert-approximately-96-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 02 May 2013 22:20:33 GMT</pubDate>
    </item>
    <item>
      <title>Impax Beats Earnings Estimate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98438/impax-beats-earnings-estimate.aspx</link>
      <author>Zacks</author>
      <pubDate>Thu, 02 May 2013 08:32:01 GMT</pubDate>
    </item>
    <item>
      <title>Impax Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1392231-impax-laboratories-management-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 22:10:04 GMT</pubDate>
    </item>
    <item>
      <title>Glaxo-Impax End Rytary Deal - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98292/glaxo-impax-end-rytary-deal.aspx</link>
      <author>Zacks</author>
      <pubDate>Tue, 30 Apr 2013 16:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Impax Pharmaceuticals and GlaxoSmithKline Terminate Their Collaboration on IPX066 (RYTARYTM)</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/29/impax-pharmaceuticals-and-glaxosmithkline-terminat/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 29 Apr 2013 09:36:14 GMT</pubDate>
    </item>
    <item>
      <title>GSK, Impax End Collaboration on IPX066 Parkinson's Treatment</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130429-000172&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Mon, 29 Apr 2013 08:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Impax, Glaxo Terminate Collaboration for IPX066</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3537181/impax-glaxo-terminate-collaboration-for-ipx066.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 29 Apr 2013 08:03:20 GMT</pubDate>
    </item>
    <item>
      <title>FDA Bars Old OxyContin Generics: Read-Through To Continue Boosting Endo</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1347941-fda-bars-old-oxycontin-generics-read-through-to-continue-boosting-endo.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 12:08:41 GMT</pubDate>
    </item>
    <item>
      <title>Good News for Warner Chilcott - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97088/good-news-for-warner-chilcott.aspx</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 16:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Curing Parkinson's: The Alternative Approach - Is There Money To Be Made?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1320381-curing-parkinson-s-the-alternative-approach-is-there-money-to-be-made.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 04 Apr 2013 09:29:13 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Spiking on Big Volume</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-stocks-spiking-big-volume.html-3.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 03 Apr 2013 15:11:00 GMT</pubDate>
    </item>
    <item>
      <title>Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/03/impax-laboratories-schedules-conference-call-and-w/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 03 Apr 2013 08:36:46 GMT</pubDate>
    </item>
  </channel>
</rss>
